Literature DB >> 15127825

Chiral separation of tamsulosin isomers by HPLC using cellulose tris (3,5-dimethhylphenylcarbamate) as a chiral stationary phase.

Zhefeng Zhang1, Gengliang Yang, Guijian Liang, Haiyan Liu, Yi Chen.   

Abstract

A high-performance liquid chromatographic (HPLC) method was developed for the chiral separation of an antagonist of alpha1A adrenoceptors, tamsulosin and its S-isomer. Baseline separation of the isomers was achieved within 35 min on a CHIRALCEL OD-RH column with a binary solvent mixture of 50 mmol l(-1) KPF6-acetonitrile (v/v (70:30), pH 5.0) as the optimized mobile phase. The detection limits and quantification limits of both R-isomer and S-isomer were 0.11 and 0.44 ng, respectively. The R.S.D. values of peak-area for the two isomer were 0.42% (of peak-height: 0.77%) for R-isomer and 0.64% (of peak-height:0.92%) for S-isomer (n = 5).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127825     DOI: 10.1016/s0731-7085(03)00555-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Stability Indicating HPLC Method for the Determination of Chiral Purity of R-(-)-5-[2-aminopropyl]-2-methoxybenzene Sulfonamide.

Authors:  G B Kasawar; M N Farooqui
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

2.  RP - HPLC method for the estimation of Tamsulosin Hydrochloride in Tablet Dosage Form.

Authors:  Richa Kumari; P P Dash; V K Lal; A Mishra; P N Murthy
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

3.  Spectrophotometric estimation of tamsulosin hydrochloride by acid-dye method.

Authors:  Alankar Shrivastava; Prachi Saxena; Vipin B Gupta
Journal:  Pharm Methods       Date:  2011-01

4.  Validated spectrophtometric method for determination of tamsulosin in bulk and pharmaceutical dosage forms.

Authors:  Massoud Amanlou; Amin Ghazi Moghadam; Maliheh Barazandeh Tehrani; Effat Souri
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.